Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03549559

Imaging Histone Deacetylase in the Heart

Imaging of Histone Deacetylase in the Heart

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The overall goal of this PET-MR imaging trial is to evaluate 11C-Martinostat, a histone deacetylase targeted radioligand, in patients with aortic stenosis, individuals with diabetes, and healthy volunteers.

Detailed description

Histone deacetylases (HDACs), a class of epigenetic enzymes, play an important role in the pathophysiology of heart failure, including development of left ventricular hypertrophy and myocardial fibrosis. Preclinical data demonstrate the importance of HDAC inhibition in attenuating these pathological processes and maintaining the integrity of the myocardium. However, the role of HDACs in the human heart, and the utility of HDAC inhibition remains unknown. Therefore, a noninvasive method to detect HDAC activity in the human heart in healthy individuals and patients with heart disease may be of major medical and public health value to help determine prognosis, direct therapy, and guide the development of novel therapies for heart failure. The investigators have recently developed a novel radiotracer, 11C-Martinostat, which binds with high affinity to class I HDACs. The objective of this protocol is to assess the utility of 11C-Martinostat PET-MR to detect HDAC expression in the hearts of healthy individuals and patients with severe aortic stenosis or diabetes.

Conditions

Interventions

TypeNameDescription
DRUG11C-MartinostatImaging probe for evaluating the activity of histone deacetylase in the heart
DEVICEPET-MRISiemens PET-MR Scanner (Biograph MMR)

Timeline

Start date
2018-09-07
Primary completion
2026-03-01
Completion
2026-09-01
First posted
2018-06-08
Last updated
2025-12-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03549559. Inclusion in this directory is not an endorsement.